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Abstract
Background: Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The
expression and distribution of Wnt5a and its receptors frizzled (fzd) 3 and fzd 5 in adult human skin have not been
comprehensively studied to date.
Methodology/Principal Findings: We here show that Wnt5a, fzd3, fzd5, as well as fzd6 are restricted to specific layers in
normal epidermis, analogous to their zonal distribution in hair follicles, suggesting a role in adult skin differentiation. In line,
Wnt5a and fzd5 are both overexpressed and re-distributed in the epidermis of psoriasis which involves disturbed
keratinocyte differentiation. Functionally, Wnt5a lowers the concentration of IFN required to induce target genes, and
increases the magnitude of IFN target gene induction, suggesting a molecular mechanism underlying IFN hypersensitivity in
psoriasis. Finally, we identify nedd8 and the amyloid precursor APP, previously shown to be upregulated in psoriasis, as
targets of synergistic IFNa/Wnt5a induction.
Conclusions/Significance: The present data (i) suggest that Wnt5a regulates epidermal differentiation even in adult skin
and (ii) identify synergistic induction of type 1 IFN target genes as a novel mode of Wnt5a action. Targeting Wnt5a in the
skin may reduce IFN hypersensitivity and be of therapeutical value.
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Introduction
Wnt proteins regulate diverse biological processes. Wnt5a
represents the prototypical so-called non-canonical Wnt family
members which signal not by inducing, or may even inhibit, the
transcriptional activation of b-catenin. Apart from its complex role
in development, Wnt5a is expressed in various adult tissues.
Among its diverse biological activities, Wnt5a promotes prolifer-
ation in endothelial cells and glioblastoma cells [1–3], as well as
adhesion in fibroblasts and breast cancer cells [4,5]. Most recently,
evidence has accumulated for the involvement of Wnt5a in
inflammatory responses and innate immunity. Thus, Wnt5a is
induced by Toll-like receptors and elicits secretion of IL12 and
TNFa in response to mycobacterial infection [6]. Furthermore,
Wnt5a is drastically upregulated in macrophages by LPS and
IFNc and induces the production of the pro-inflammatory
cytokines IL1, IL6, and IL8 [7]. Wnt5a is also upregulated in
synovial fibroblasts of inflammatory joints in rheumatoid arthritis
where it induces IL6, IL8, and IL15 [8].
The signal transduction of Wnt5a appears to be context-
dependent [9]. In all of the inflammatory responses cited above, as
well as in endothelial cell activation, the active receptor appears to
be Frizzled (Fzd) 5 [10]. However, signalling through Fzd3, and
Ror2 have been described [4,9].
The epidermis represents a dynamic system of highly regulated
keratinocyte stem-cell renewal, proliferation, differentiation, and
migration. At the same time, the epidermis acts as first-line barrier
in innate immunity and, as such, maintains complex communi-
cation with resident dendritic cells and sub-epidermal endothelial
cells and fibroblasts. Although Wnt5a is expressed in all of these
cell types and its role in the development of skin appendages
including hair follicles [11] and mammary glands [12] has been
examined, surprisingly little is known about the expression,
distribution, and function of Wnt5a in post-natal human
epidermis.
Psoriasis is a very common chronic inflammatory skin disease
with a prevalence of 2–4% in Caucasian populations. In psoriasis,
keratinocyte proliferation as well as differentiation are perturbed,
leading to a grossly thickened epidermis with an altered
composition of normal epidermal layers. Apart from keratinocyte
turnover, psoriasis involves a hyperactive innate immune response.
Thus, iatrogenic administration of type 1 IFN (IFNa or IFNb)
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IFN release in the course of viral disease [13,14]. Moreover,
keratinocytes from psoriasis patients are hypersensitive to type 1
IFN [15] and epidermal dendritic cells produce IFNa leading to
massive upregulation of type 1 IFN target genes [16]. Indeed,
hypersensitivity towards type 1 IFN induced by deletion of the IFN
repressor IRF2 is sufficient to cause a psoriasis-like skin disease in
mice [17].
We and others have previously found Wnt5a to be
upregulated on the mRNA level in psoriasis [16,18]. Here, we
show that Wnt5a and its putative receptors are localized to
specific compartments in normal skin and that Wnt5a is both
highly upregulated and re-distributed in the hyperproliferative
epidermis in psoriasis. Functionally, we show that Wnt5a
sensitizes keratinocytes towards type 1 IFN. Finally, we identify
nedd8 and APP as novel targets of synergistic IFN/Wnt5a
activation.
Materials and Methods
Immunohistochemistry
Paraffin-embedded samples were obtained from the Tayside
Tissue bank. Prior to biopsy, patients gave written consent to
storage and analysis of biopsy samples. Storage and use of all
tissues included in the work presented here was approved by the
Tayside Committee on Medical Research Ethics B (REC ref.
Nr. 07/S1402/90). Antibodies used were anti wnt5a (R&D, order
nr. AF645, final dilution 1:400), anti-frizzled 3 (Insight Biotech,
ordered through Acris Antibodies, Germany, order nr. SP4568P,
1:200), anti-frizzled 5 (Cambridge Bioscience, ARP41245_P050,
1:800), anti-frizzled 6 (GenWay, 18-461-10538, ordered through
Acris Antibodies, Germany; 1:400). A detailed protocol is given in
Supporting Methods S1.
Keratinocyte primary culture and western blot
All studies on human samples were done with prior
approval of the local institional ethics committee. Processing
of biopsy samples and primary keratinocyte culture was
performed as described [16]. Cells were fractionated using
the NE-PER kit (Pierce, order-nr 78833) and 20 mgo fp r o t e i n
loaded per lane onto 15% acrylamide-SDS gels. Blotting was
performed on a semi-dry blotter onto nitro-cellulose mem-
branes (Schleicher & Schell, 10 402 594). Blots were blocked
in Tris-buffered saline containing 0.1% Tween-20 (TBST) and
incubated with primary antibodies in TBST containing 4%
d r ym i l ka sf o l l o w s :r a b b i ta n t i - human nedd8 (Cell Signaling,
#2745) and rabbit anti-human Amyloid b precursor protein
(Biozol, ab12269) at 1:1000, respectively, overnight at 4uC.
Secondary antibody was anti-rabbit-HRP (Amersham Biosci-
ences, NA934) at 1:2000 for 1 h at RT. Blots were developed
with ECL Plus (Amersham #RPN2 132) and scanned with a
CCD camera.
Stimulation with Wnt5a-mimic peptide and IFNa
Formylated hexapeptide formyl-MDGCEL [5] was synthesized
by Pepscan Systems, reconstituted to 10 mM in PBS, aliquoted
and stored at 280uC. Primary keratinocytes at 50% confluence
were stimulated with 100 mM final concentration of Wnt5a-mimic
peptide for 18 h. Stimulation with recombinant human IFNa
(PBL Biomedical Labs, order-nr 3410) was carried out analogously
with 20 ng/ml final concentration. For the concentration
response, final concentrations were 3, 10, 30, 100 und 300 ng/
ml, respectively.
Expression profiling
RNA was isolated and reverse transcribed to cDNA as described
[16]. cDNA was fluorescence-labelled, hybridized to SkinPatho
microarrays (Miltenyi Biotech), and scanned by the in-house
microarray facility of the Charite ´ Medical University, Berlin,
Germany. Raw data were adjusted for red/green bias. Excel-
based auto-filtering was used to exclude all transcripts lower than
ten fluorescence units above the detection threshold in both the
red- and green-labelled samples. P-values were determined using a
standard t-test as indicated in the respective tables.
Wnt5a transfection
Full-length human wnt5a cDNA was purchased from Origene.
Five610
5 HaCat keratinocytes were cultivated in RPMI1640
medium and transfected in Advanced Medium (Gibco, order-
nr 12491015) containing 2% FCS with 40 mg Wnt5a-pCMV-XL4
or control vector (pCDNA6.1) using CaCl2 precipitation as
previously described for transfection of lentiviral vectors [19].
RT-PCR
RNA was extracted using the NucleoSpin II extraction kit
(Machery-Nagel, #740 955) and cDNA prepared using Super-
Script II RT, RnaseOut, Oligo(dT)12-18 from Invitrogen. For PCR
reactions, annealing temperature was uniformally 55uC. All genes
were amplified for 25 cycles, except for wnt5a and IFI27 (30
cycles). Primers and conditions are detailed in Supporting
Methods S1.
Results
Dysregulation of Wnt-signalling in hyperproliferative
epidermis
Psoriasis is a skin disease characterized by hyperproliferation, as
well as aberrant differentiation of epidermal keratinocytes. In the
course of extensive expression profiling we previously noted that
the non-canonical Wnt family member Wnt5a was greatly
upregulated in psoriatic epidermis [16]. Accordingly, we carried
out a more comprehensive expression analysis of Wnt-signalling
molecules in psoriatic skin. As shown in table 1, only Wnt5a and
Fzd6 were significantly upregulated whereas the b-catenin
inhibitor ICAT was downregulated (shown in bold print), in
confirmation of previous findings [18,20].
Expression of Wnt5a and Fzd receptors in adult human
epidermis
Before analyzing Wnt5a expression in psoriasis on the protein
level, we first performed a detailed immunohistochemical
expression analysis in normal adult human skin which has not
been published to date. We included Fzd3 and Fzd5 in this
analysis, since these have been reported to bind Wnt5a, as well as
Fzd6, as it was found upregulated in psoriasis (table 1) and
squamous cell carcinoma [18]. The epidermal expression profiles
are shown in figure 1. Wnt5a is mainly expressed in the basal layer
and few cells in the upper spinous and granular layers. Fzd3 was
found to be strictly confined to the spinous layer in the epidermis
and was the only receptor exhibiting a non-homogeneous patchy
expression pattern such that strongly positive cells are intersperced
with Fzd3-negative cells in a mosaic-like pattern. Fzd5 expression
is strictly limited to the granular layer (magnified inset) whereas
Fzd6, similar to Wnt5a, is mainly found in the basal layer,
corresponding to its distribution in murine skin [21] (fig. 1e
therein). In the hair follicle, Fzd 3 is mainly expressed in the inner
root sheath, Fzd 5 in the precortex, and Wnt5a in the papilla
Wnt5a in Psoriasis
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in postnatal murine skin [11,22], thereby also confirming the
specificity of the antibodies employed here. In addition, we also
observe Fzd6 expression in the cortex. Taken together, the highly
compartmentalized distribution of Wnt5a and Fzd isoforms in
adult human epidermis is reminiscent of their zonal restriction in
hair follicles (see fig. 2, lower right), strongly suggesting that Wnt
signalling regulates differentiation not only in hair follicles, but also
in the epidermis.
Expression of Wnt5a and receptors in psoriasis
We next characterized the expression of Wnt5a, Fzd3, Fzd5,
Fzd6 in psoriasis lesions which are characterized by hyperproli-
feration and dysregulated differentiation. As shown in figure 3,
Wnt5a was found to be overexpressed throughout the entire
spinous layer. Moreover, as shown in the top panel on the right,
activated endothelials cells and dermal fibroblasts are strongly
positive for Wnt5a. Finally, the neutrophil aggregates in the
stratum corneum, a hallmark of psoriasis, also express Wnt5a
(arrow, top left panel). While Fzd3 shows an expression pattern
qualitatively unchanged to normal epidermis, Fzd5 is shifted from
its exclusive expression in the granular layer towards overexpres-
sion in all epidermal layers as well as expression in the dermal
endothelia (high power image on right). Fzd6 is also heavily
overexpressed as well as in the endothelia but retains the same
relative expression level as in normal epidermis (strongest staining
in the basal layer). Taken together, Wnt5a, Fzd5, and Fzd6 are
strongly upregulated in psoriasis. In addition, Wnt5a and Fzd5
exhibit an altered qualitative distribution.
Overexpression of Wnt5a in keratinocytes from psoriasis
patients in vitro
We next sought to clarify whether any of the observed changes
represent a cell-autonomous feature of the hyperproliferative
keratincoytes in psoriasis patients, i.e. whether they can be
detected in vitro in the absence of the inflammatory micro-
environment. To this end, we expanded keratinocytes from non-
lesional skin of psoriasis patients, or healthy control patients, in
vitro and performed microarray-based expression profliling. As
shown in table 2, Wnt5a was found significantly upregulated on
the mRNA level in keratinocytes derived from psoriasis patients.
This was not the case for Fzd3 and Fzd5 (Fzd6 was not
represented on the Skin-Patho microarray used for this
experiment). By western blot, we were able to confirm that
Wnt5a protein is indeed overexpressed in primary human
keratinocytes expanded from non-lesional skin of psoriasis
patients (fig. 4). Although the low sample number precludes a
definite statement, these data suggest that upregulation of Wnt5a
may constitute of cell-autonomous feature of psoriatic keratino-
cytes. Regardless of this notion, the clear difference in Wnt5a
expression between the psoriasis- and control-derived keratino-
cytes characterized here is suitable to study effects of endogenous
Wnt5a overexpression (see below).
Wnt5a induces type I interferon target genes
In order to screen for cellular signalling pathways possibly
affected by Wnt5a in keratinocytes, we stimulated keratinocytes in
vitro with a formylated wnt5a-derived hexapeptide shown to
mimic the effect of full-length wnt5a on adherence and motility in
vivo and in vitro [5,23] and compared global gene expression
between keratinocytes stimulated with Wnt5a-mimic peptide and
control peptide. We performed this experiment both with
keratinocytes from psoriasis patients and from control patients.
Since there were no significant differences in the effect of the
Wnt5a-mimic peptide on keratinocytes from psoriasis patients and
controls (not shown), both groups were analyzed together. Of the
1133 transcripts represented on the Piquor SkinPatho microarray,
only four exhibited a greater than 1.2-fold change: nedd8, MX1
(IFI-78), IFI-27, and APP (table 3). Both MX1 and IFI-27 are type
Table 1. Expression of Wnt-related genes in psoriasis.
1
Gene Location p-value fold change
Wnt proteins
WNT1 12q13 - n.d.
WNT2 7q31 0.83 1.07
WNT2B 1p13 - n.d.
WNT4 1p36.23-p35.1 0.78 21.06
WNT5A 3p21-p14 0.0004 4.54
WNT6 2q35 0.017 1.79
WNT7A 3p25 - n.d.
WNT8B 10q24 - n.d.
WNT10B 12q13 0.24 21.37
WNT11 11q13.5 0.14 21.53
Frizzled-related proteins
FZD1 7q21 0.18 21.42
FZD2 17q21.1 - n.d.
FZD3 17q21.1 0.39 21.15
FZD4 11q14.2 0.75 1.15
FZD5 2q33-q34 0.18 1.34
FZD6 8q22.3-q23.1 0.027 1.99
FZD7 2q33 0.056 21.58
FZD9 7q11.23 - n.d.
FRZB 2qter 0.45 21.41
SFRP1 8p12-p11.1 0.16 21.49
SFRP4 7p14.1 0.10 21.45
Other membrane receptors
LRP5 11q13.4 0.79 21.08
LRP6 12p11-p13 0.37 1.07
LRP1 12q13-q14 0.27 21.30
ROR2 9q22 - n.d.
RYK 3q22 0.22 21.38
Wnt-inhibitors
WIF1 12q13.13 0.24 21.58
DKK1 10q11.2 0.39 21.47
DKK4 8p11.2-11.1 0.37 1.12
Downstream effectors
DVL3 3q27 0.99 21.01
GSK3B 3q13.3 0.09 1.26
APC 5q21-q22 - n.d.
CTNNB1 3p21 0.95 1.02
CTNNBIP1 1p36.22 0.006 22.42
1Expression of wnt-signalling related molecules was analyzed using the
Affymetrix U95A microarray. Data shown represent fold-changes in psoriatic
lesional vs. non-lesional skin of n=5 independent donors, as detailed in [16].
Bold-print: p,0.05 and fold-change .1.5; n.d.: not detected.
doi:10.1371/journal.pone.0005354.t001
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psoriatic skin lesions [16]. Induction of all four target genes could
subsequently be verified by RT-PCR of HaCat keratinocytes
transfected either with full-length Wnt5a cDNA or control vector
(fig. 5a). Importantly, type 1 IFN genes themselves (a or b) were
not induced by Wnt5a (not shown).
Wnt5a causes hypersensitivity toward type 1 interferon
Since the magnitude of mRNA upregulation was rather modest
for an IFN target gene, we hypothesized that a possible function of
Wnt5a might be to ’’prime‘‘ cells for synergistic induction by type
1 IFN. To test this hypothesis, we transfected HaCat keratinocytes
either with full-length Wnt5a cDNA or control vector. Transfected
cells were then exposed to increasing concentrations of IFNa and
expression of the IFNa target gene MX1 determined by PCR. As
shown in figure 5b, concurrent overexpression of Wnt5a caused a
left shift in the concentration response curve to all IFNa where the
calculated apparent EC-50 shifted from 22 ng/ml to 6 ng/ml,
suggesting that overexpression of Wnt5a indeed increases
sensitivity toward IFNa. This observation predicts that low
concentrations of IFNa should cause a greater magnitude of
IFN target gene induction in cells with increased Wnt5a
expression. To test this, we compared the response to type 1
IFN between primary epidermal keratinocytes from psoriasis
patients harbouring increased endogenous Wnt5a protein levels
(see above, fig. 4) to keratinocytes from control probands. We
stimulated these cells with 20 ng/ml of IFNa, a concentration
which, according to the data presented above, would be expected
to cause a higher magnitude of IFNa target gene induction in
keratinocytes with endogenous Wnt5a overexpression. After 18 h
of stimulation, global gene expression was analyzed using the
Piquor SkinPatho microarray. Figure 5c shows all transcripts (41
of 1133) present on the array which were induced at least a two-
fold by IFNa. The induction level is expressed as mean fold-
change of all control keratinocytes (n=4, along the x-axis) vs.
mean fold-change of all psoriasis keratinocytes (n=3, along the y-
axis). Strikingly, all 41 IFN-responsive target genes are induced to
a higher level in the keratinocytes harbouring higher Wnt5a levels,
corresponding to a statistically highly significant 1.861.1-fold
relative hyper-induction across all target genes (p=0.001). These
data confirm that hypersensitivity toward IFNa, i.e. increased IFN
target gene induction at low IFN concentrations, is a general
feature detectable for all target genes in primary cells with
endogenous Wnt5a upregulation.
APP and nedd8 are synergistically induced by type 1 IFN
and Wnt5a
Apart from MX1 and IFI-27, the only transcripts induced by
Wnt5a in keratinocytes were APP and nedd8 (see above, table 3
and figure 5). Wnt5a alone showed only a modest induction of
both genes in keratinocytes. Likewise, stimulation by IFNa alone
only caused a slight upregulation of either gene (1.460.6 fold and
1.660.4 fold for APP and nedd8, respectively). Therefore, we
hypothesized that these genes, too, might be subject to synergistic
induction by Wnt5a and type 1 IFN. To test this hypothesis we
transfected HaCat keratinocytes either with control vector or full-
Figure 1. Expression of Wnt5a, Fzd3, Fzd5, and Fzd6 in adult human epidermis. Immunohistochemistry of paraffin-embedded skin
samples was performed as detailed in Methods. Panels shown are at 2006magnification.
doi:10.1371/journal.pone.0005354.g001
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presence or absence of 20 ng/ml IFNa. As shown in fig. 6a, a
specific band at appr. 70 kd, corresponding to soluble APP, was
induced upon either Wnt5a or IFNa stimulation, but more
strongly upon co-stimulation with both factors. Synergistic
induction of soluble APP is also evident upon densitometric
quantification of the blot, as shown on the bottom of the figure.
Nedd8 is a ubiquitin-like peptide covalently linked to a number of
target proteins. In nuclear extracts of HaCat cells, a nedd8-
reactive protein migrating at appr. 50 kd was present in control
cells, but more abundant after either Wnt5a-transfection or IFNa
stimulation and clearly synergistically induced by both factors
(fig. 6b), which is also seen upon densitometric quantification. In
conjunction with the transcriptional induction of nedd8 by IFNa
as well as Wnt5a seen on the mRNA level (figure 4a), these data
strongly suggest that nedd8 is synergistically induced by Wnt5a
and IFNa. Taken together, APP (previously implicated in psoriasis
pathogenesis) and nedd8 represent novel interferon targets
induced significantly by the concurrent action of Wnt5a and
IFNa.
Discussion
We here show that Wnt5a and its putative receptor Fzd5 are
overexpressed in psoriasis, that Wnt5a increases the sensitivity of
keratinocytes towards type 1 interferon, and that nedd8 and APP
are synergistically induced by Wnt5a and IFNa.
The unexpected finding that Wnt5a and fzd3, fzd5, and fzd6
proteins are highly compartmentalized in normal adult human
epidermis, reminiscent of the distribution of wnt signalling
components in the hair follicle, raises the question of the role of
this system in the dynamics of keratinocyte turnover in the skin. Of
all relevant classical knock-out phenotypes, only Fzd6-deficient
mice survive post term with intact epidermis except for abnormal
hair whorls [21], suggesting that its physiological presence in
the basal layer is dispensable. Therefore, inducible loss- or gain-of-
function approaches will be required to delineate the functional
role of wnt signalling in post-natal skin.
The marked overexpression of Wnt5a and Fzd5 in psoriasis
suggest that this ligand-receptor pair may actively drive the chronic
inflammatory and hyperproliferative nature of this phenotype. This
idea receives further support from a large body of circumstantial
evidence. First, WNT5a induces IL12 [6], which is central to
psoriasis, as indicated by the therapeutic efficacy of antibodies
targeted at IL12p40 and by the genetic association of IL12 with
psoriasis [24,25]. Second, Wnt5a is itself strongly induced by
STAT3 [26], thereby acting as a potential effector molecule for the
psoriasis-like skin disease seen in STAT3-overexpressing transgenic
mice [27]. Third, WNT5a induces epithelial differentiation and
stimulates endothelial cell proliferation, both important elements of
psoriasis. Fourth, Wnt5a is upregulated in wound healing [28] and
psoriasis lesions can classically be triggered by skin wounding. Fifth,
our data show that dermal fibroblasts in psoriasis are strongly
positive for Wnt5a and activated fibroblasts from rheumatoid
arthritis are synthesize inflammatory cytokines, most notably IL15,
subsequent to Wnt5a/Fzd5 signalling [29]. Sixth, Wnt5a derived
from endothelia signals through Fzd5 to induce the translocation of
NFAT and subsequent induction of IL-2 in T cells [10]. This effect
may be highly relevant, since (i) continued T cell activation also
represents a central element in psoriasis [30], and (ii) Wnt5a-
Figure 2. Expression of Wnt5a and Fzd3, Fzd5, and Fzd6 in adult human hair follicles. Immunohistochemistry of paraffin-embedded skin
samples was performed as detailed in Methods. Panels shown are at 2006magnification. The hair follicle schematic for the cartoon on lower right
was adapted from [11].
doi:10.1371/journal.pone.0005354.g002
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the most potent clinical triggers of psoriasis flares [31]. Finally, and
mostimportantly, WNT5a induces IFN hypersensitivity (see below),
a central hallmark of psoriasis.
The relationship between Wnt5a and b-catenin signalling in
psoriasis as well as physiological epidermal turn-over is unclear.
Supra-basal accumulation of nuclear b-catenin in psoriasis has
been reported [32]. Moreover, we here report down-regulation of
two inhibitors of canonical wnt-signalling in psoriasis, ICAT
(CTNNBIP1) and WIF (table 1). Furthermore, the psoriasis-
inducing effect of lithium mentioned above may also involve
GSKb-inhibition and b-catenin activation in vivo. Thus, Wnt5a
and b-catenin activation may occur concurrently in psoriasis.
Indeed, retroviral overexpression of Wnt5a after wounding in mice
did not antagonize nuclear translocation of b-catenin [28].
Wnt5a signalling in psoriasis may also be related to the
activation of the nuclear hormone receptor PPARd which we have
previously identified as a central mediator in psoriasis. Thus,
Wnt5a may synergize with IFNa to induce the expression of
PPARd in activated T lymphocytes [29]. Moreover, PPARd
stimulates keratinocyte proliferation and in several biological
processes acts by antagonizing another PPAR isoform, PPARc
[16]. Wnt5a also represses PPARc transactivation thereby
synergizing with PPARd functionally [33]. Conversally, PPARc
inhibits STAT3 [34] which, when overexpressed, induces Wnt5a
and causes a psoriasis-like phenotype in vivo [27].
The molecular mechanism of Wnt5a/IFNa crosstalk is elusive
as no data exist on the effect of frizzled-mediated signalling on
downstream effectors of IFN signalling. Our results do suggest that
Fzd5 may be the responsible molecule at the receptor level and
Figure 3. Expression of Wnt5a and Fzd proteins in psoriasis. (a) Immunohistochemistry of Wnt5a was performed as detailed in Methods.
Panels on left are 2006, panels on right are at 4006 magnification. Wnt5a staining was virtually identical in n=12 samples from independent
patients.
doi:10.1371/journal.pone.0005354.g003
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issue. Moreoever, our data do not show a direct transcriptional
upregulation of IFN genes or IFN receptors (data not shown) by
Wnt5a activation. Down-stream of the membrane receptor, it is
less clear at which point Fzd-mediated signals interact with IFN
signalling relayers [35]. The present data should certainly prompt
a more detailed analyses of the effect of Wnt5a on nuclear
translocation and phosphorylation of factor involved in IFN signal
transduction.
We here identify the APP amyloid precursor protein and the
ubiquitin-like molecule nedd8 as bona fide targets of synergistic
IFNa/Wnt5a induction. APP is upregulated and re-distributed in
psoriasis lesions strikingly similar to Wnt5a and APP stimulates
both proliferation and mobility of keratinocytes [36,37]. Further-
more, processed amyloid b induces transcription of kynureninase,
which we found to be strongly upregulated in psoriasis in vivo, as
well as in psoriasis-derived cells in vitro (table 2), and which can
elicit an inflammatory skin reaction in vivo [38]. Therefore, the
induction of APP by Wnt5a/IFN may contribute to increased
keratinocyte turnover and migration in psoriasis. As for nedd8,
further studies must clarify which target proteins are neddylated by
concurrent Wnt5a/IFN stimulation and whether these are
involved in epidermal dynamics. However, the results presented
here clearly show that, in addition to established IFN target genes,
another class of targets exists which are synergistically induced by
Wnt5a/IFNa. Thus, screening for such targets in other cell types
such as T cells, endothelial cells, or fibroblasts, would delineate the
profile of innate immune activation elicited by Wnt5a.
In conclusion, we here demonstrate compartmentalized distri-
bution of Wnt-signalling components in adult skin, up-regulation
Table 3. Genes induced in keratinocytes by Wnt5a in vitro.
1
Gene ID fold change p-value
2
Psoriasis Controls Total
NEDD8 1.34 1.35 1.35 2610
27
IFI-78 (MX1) 1.53 1.16 1.35 0.14
IFI27 1.52 1.12 1.32 0.11
APP 1.41 1.14 1.28 0.002
1Primary keratinocytes expanded from healthy control donors (n=3) or psoriasis patients (n=3) were cultivated in the presence or absence of Wnt5a mimic peptide [5]
or control peptide for 48 h and gene expression subsequently analyzed as detailed in Methods. Total fold-changes shown represent the average across all six samples
(wnt5a vs. control peptide).
2As determined by a two-sided paired t-test.
doi:10.1371/journal.pone.0005354.t003
Table 2. Genes with altered expression in cultured psoriatic
keratinocytes.
1
FC in vitro
2 p-value
3 FC skin
4 p-value skin
4
Increased expression
KYNURENINASE 5.5 0.003 3.4 0.06
COL3A1 3.2 0.006 2.9 0.018
COL5A2 3.1 0.006 n.s. n.s.
COL6A1 3.0 0.000 n.s. n.s.
WNT5A 2.9 0.003 4.5 0.0004
COL1A1 2.5 0.009 n.s. n.s.
CXCL1 (GRO1) 2.0 0.008 n.s. n.t.
MMP2 1.8 0.008 n.s. n.s.
Decreased expression
ARHE (Rho8) 0.6 0.002 3.3 0.005
PLK2 (SNK) 0.5 0.010 2.4 0.002
1Keratinocytes from non-lesional skin of psoriasis patients (n=3) or normal
control skin (n=4) were expanded in vitro and cultured for appr. 14 days,
followed by expression profiling using the PIQUOR Skin-Patho microarray, as
detailed in methods.
2Fold change (relative expression levels in keratinocytes from psoriasis patients
vs. controls).
3Statistical significance, as determined by a non-paired two sided t-test.
4Overexpression in lesional vs. non-lesional psoriatic skin, as previously reported
[16].
doi:10.1371/journal.pone.0005354.t002
Figure 4. Overexpression of Wnt5a in psoriatic keratinocytes in vitro. Keratinocytes from non-affected skin from psoriasis patients or
healthy control skin were expanded in vitro for 14 days, fractionated in nuclear (n) or cytoplasmic/membrane fractions (c/m), and subjected to
western blot, as detailed in Methods. 50 mg of protein were loaded per lane. The bottom panel shows the Poinceau-S stain of the blot verifying even
protein loading. *=non-specific band also visible in the Poinceau S stain.
doi:10.1371/journal.pone.0005354.g004
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epidermis, and identify sensitization for interferon as a novel
function of Wnt signalling.
Supporting Information
Supporting Methods S1
Found at: doi:10.1371/journal.pone.0005354.s001 (0.06 MB
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Figure 5. Wnt5a induces type 1 IFN target genes and causes IFN hypersensitivity. (a) HaCat keratinocytes were transfected with full length
Wnt5a cDNA or control vector (pCDNA6.1). 12 h after transfection, the expression of nedd8, MX1, IFI-27, and APP was determined by RT-PCR, as
described in Methods. The expression of Wnt5a was also determined to verify overexpression. (b) HaCat keratinocytes transfected with full-length
Wnt5a cDNA (open symbols) or control vector (closed symbols) and stimulated with the indicated concentrations of IFNa for 18 h. The expression of
IFI27 was then assessed using RT-PCR and quantified densitometrically. The data shown represent mean6s.d. of two independent experiments. (c)
Keratinocytes from non-lesional psoriatic skin with elevated endogenous Wnt5a levels or from healthy control skin were expanded in vitro for 14 days
and stimulated for 18 h with 20 ng/ml IFNa. Global gene expression was determined using the piquor skin-patho microarray. Plotted are the –fold
change (IFNa vs. basal expression) of all genes (41 of 1133) exhibiting a $2-fold induction by IFNa. The mean fold-changes of cells from n=3 controls
are plotted along the x-axis, the mean fold-change of cells from n=4 cells are plotted along the y-axis. Dots represent mean values, horizontal lines
represent s.d. among the controls, vertical lines represent s.d. among cells from psoriasis patients. The dashed line marks the theoretical equal
magnitude of gene induction.
doi:10.1371/journal.pone.0005354.g005
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